Get started
Author

Mehmet Baysal

Observed names: BAYSAL, MEHMET, Baysal, Mehmet, M Baysal, M. Baysal, Mehmet BAYSAL
ORCID: 0000-0001-7681-4623
Observed ORCID: 0000-0001-7681-4623
OpenAlex ID: A5029669913
Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
2020 · Mehmet Baysal, Ufuk Demirci, et al. · Scientific Reports · 64
PDF
The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease
2017 · Can Sevinc, Gulay Yilmaz, et al. · Saudi Journal of Kidney Diseases and Transplantation · 40
Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy
2019 · Elif G Umıt, Mehmet Baysal, et al. · Journal of Oncology Pharmacy Practice · 27
Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia, Effects on Epistaxis Severity Score and Quality of Life
2018 · Mehmet Baysal, Elif G Ümit, et al. · Turkish Journal of Hematology · 24
PDF
Frailty in patients with acute myeloid leukaemia, conceptual misapprehension of chronological age
2018 · E.G. Umit, M. Baysal, et al. · European Journal of Cancer Care · 19
The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review
2024 · Mehmet Can Ugur, Mehmet Baysal, et al. · Journal of Clinical Medicine · 17
PDF
The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients
2021 · M Baysal, V Bas, et al. · Nigerian Journal of Clinical Practice · 16
Evaluation of Sarcopenia with F‐18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma
2020 · Elif G. Umit, Ulku Korkmaz, et al. · European Journal of Cancer Care · 15
PDF
The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma
2020 · Onur Kirkizlar, Tugcan Alp Kirkizlar, et al. · Clinical Lymphoma Myeloma & Leukemia · 15
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients
2024 · Zehra Narlı Özdemir, Yıldız İpek, et al. · Turkish Journal of Hematology · 13
PDF
Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia
2020 · Mehmet Baysal, Elif Ümit, et al. · Turkish Journal of Hematology · 13
PDF
CD 11c expression in chronic lymphocytic leukemia revisited, related with complications and survival
2017 · E. G. Umit, M. Baysal, et al. · International Journal of Laboratory Hematology · 13
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
2023 · Hannah Cohen, David J. Werring, et al. · Journal of Thrombosis and Haemostasis · 11
PDF
Sarcopenia in Hodgkin’s lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment
2020 · Volkan Bas, Elif Gulsum Umit, et al. · Supportive Care in Cancer · 11
Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review
2023 · Mehmet Baysal, Meltem Bayrak, et al. · Expert Review of Hematology · 10
The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study
2022 · Mehmet Baysal, Vildan Gürsoy, et al. · Annals of Hematology · 10
Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?
2021 · Mehmet Baysal, Volkan Baş, et al. · Turkish Journal of Hematology · 8
PDF
The past, present, and future of myeloma staging and risk prognostication
2025 · Mehmet Baysal, Kelley Julian, et al. · The Oncologist · 7
Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology
2024 · Mehmet Baysal, Elif Aksoy, et al. · Journal of Thrombosis and Thrombolysis · 7
Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
2018 · Mehmet Baysal, Elif Gülsüm Ümit, et al. · Balkan Medical Journal · 7
PDF
Is JAK2V617F Mutation the Only Factor for Thrombosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms?
2015 · Mehmet Sevki Uyanik, Mehmet Baysal, et al. · Indian Journal of Hematology and Blood Transfusion · 7
PDF
Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores
2023 · Mehmet Baysal, Fehmi Hindilerden, et al. · Turkish Journal of Hematology · 6
PDF
Two Novel ENG Pathogenic Variations and Genotype-Phenotype Correlations in Hereditary Hemorrhagic Telangiectasia Patients
2019 · Mehmet Baysal, Selma Demir, et al. · Balkan Medical Journal · 6
Value of Extracellular High Mobility Group Box 1 (HMGB1) in the Clinical Context of Immune Thrombocytopenia
2019 · Elif G Umit, Mehmet Baysal, et al. · Journal of Clinical and Experimental Investigations · 6
PDF
Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye
2025 · Vildan Gursoy, Mehmet Baysal, et al. · Diagnostics · 5
Works count: 82
Citation count: 427
H-index: 12
I10-index: 16
Year
Topic
Type